TOKYO -- Hitachi plans to invest 300 billion yen ($2.7 billion) in research and development in the medical and health care sector, as well as find opportunities for mergers and acquisitions in those businesses between now and the end of fiscal 2023, Nikkei has learned.
Hitachi will concentrate investment and management resources in fields where data analysis technologies can be utilized, such as in the risk assessment of contracting particular diseases and the development of regenerative medicines. The move is part of the company's plans to seek growth opportunities post-pandemic.
